Track topics on Twitter Track topics that are important to you
A feasibility study to investigate the safety and performance of the NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System
A single-arm study to observe NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System hemodynamic and other physiologic effects.
A single-center feasibility study in patients undergoing cardiac catheterization, to investigate the acute hemodynamic effects of transvenous cardiac autonomic nerve stimulation.
NeuroTronik was founded in July 2012 to pursue a novel neurostimulation therapy for the enhancement of heart function in the hospital or clinic. The therapy approach was conceived...
We have published hundreds of NeuroTronik news stories on BioPortfolio along with dozens of NeuroTronik Clinical Trials and PubMed Articles about NeuroTronik for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroTronik Companies in our database. You can also find out about relevant NeuroTronik Drugs and Medications on this site too.
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...